CVS Health (NYSE: CVS) isn't having a good year. It is facing multiple headwinds and slow revenue growth, and investors are reacting in kind. The company's shares are down by 26% since January.

The old, boring, ugly, ad-heavy, info-light, promos-a-go-go newsletter that so many of us are used to getting has, in the ...

The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The fall of 2023 was filled with frustration from customers across Kansas City forced to find new pharmacy options.

The Senate on Thursday adopted an emergency spending bill to fill a nearly $3 billion shortfall in the Department of Veterans ...

Tard's bid to acquire Seven & i faces significant hurdles. Find out why I think ANCTF stock is a buy while SVNDY stock is a ...

Presented by TikTok Europe By SARAH WHEATON with ZOYA SHEFTALOVICH PRESENTED BY Send tips here | Tweet @NicholasVinocur ...

A teacher at the centre of a row over a transgender student has been sent to prison for a third time by a Dublin court ... start of the new term. When Sky News spoke to him at the school gates ...

This week's letters to the editor focus on politics, the race between Kamala Harris and Donald Trump, and John Zarbano for US ...

In addition to the slightly inflated grocery store prices you incur by shopping through the Instacart service, the add-on ...